However, in the node-positive subgroup, ER-β positivity (HR 1.55, CI 1.93 to 2.57, P = 0.09) emerged as an adverse prognostic factor for DFS along with tumor size (HR 2.51, CI 1.40 to 4.50, P = 0.002). The gene discussed is ESR2; the disease is neoplasm.